Radiation induced radionecrosis

Alsan Cetin Ilknur 1, Tuncyurek Ozum 2, Dayanır Ozsunar 2

Abstract


Radiotherapy (RT) in cancer treatment is a standard approach. Radiation necrosis (RN) may occur as late side effects of radiotherapy. It is difficult to detect. The main dilemna is the differential diagnosis of recurrence and necrosis. Because of this, cutting edge technological improvements are usually applied for reliable diagnosis of the remnant brain lesion. Those include perfusion, diffusion and spectroscopic MRI examination. Conventional and advances radiological techniques were compared. In this study we aimed to investigate causes of radionecrosis, diagnosis and treatment. 


Keywords


cranial radiotherapy; radionecrosis; diagnosis

Full Text:

PDF

References


Sheline G. Radiation therapy of brain tumors. Cancer 1977; 39: 873–81.

Aziz T, Peress NS, Diaz A, et al. Postmortem neuropathological features secondary to boron neutron capture therapy for glioblastoma multiforme. J Neuropathol Exp Neurol 2000; 59: 62–7.

Hall EJ, Wuu CS. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003; 56: 83–88.

Szeifert GT, Salmon I, Rorive S, et al. Does gamma knife surgery stimulate cellular immune response to metastatic brain tumors? A histopathological and immunohistochemical study. J Neurosurg 2005; 102: 180–184.

Uematsu Y, Fujita K, Tanaka Y, et al. Gamma knife radiosurgery for neuroepithelial tumors: Radiological and histological changes. Neuropathology 2001; 21: 298–306.

Perry A, Schmidt RE. Cancer therapy-associated CNS neuropathology: An update and review of the literature. Acta Neuropathol 2006; 111: 197–212.

Lee AW, Foo W, Chappell R, et al. Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1998; 40: 35–42.

Crossen JR, Garwood D, Glatstein E, et al. Neurobehavioral sequelae of cranial irradiation in adults: A review of radiation-induced encephalopathy. J Clin Oncol 1994; 12: 627–642.

Malone S, Raaphorst GP, Gray R, et al. Enhanced in vitro radiosensitivity of skin fibroblasts in two patients developing brain necrosis following AVM radiosurgery: A new risk factor with potential for a predictive assay. Int J Radiat Oncol Biol Phys 2000; 47: 185–89.

Kortmann RD, Timmermann B, Taylor RE, et al. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment-related late toxicity. Strahlenther Onkol 2003; 179: 585–597.

Pimperl LC. Radiation as a nervous system toxin. Neurol Clin 2005; 23: 571–597.

New P. Radiation injury to the nervous system. Curr Opin Neurol 2001; 14: 725–734.

Korytko T, Radivoyevitch T, Colussi V, et al. 12 Gy Gamma Knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors. Int J Radiat Oncol Biol Phys 2006; 64: 419–424.

Nakamura JL, Verhey LJ, Smith V, et al. Dose conformality of Gamma Knife radiosurgery and risk factors for complications. Int J Radiat Oncol Biol Phys 2001; 51: 1313–1319.

Levergrun S, Hof H, Essig M, et al. Radiation-induced changes of brain tissue after radiosurgery in patients with arteriovenous malformations: Correlation with dose distribution parameters. Int J Radiat Oncol Biol Phys 2004; 59: 796–808.

Nedzi LA, Kooy H, Alexander E III, et al. Variables associated with the development of complications from radiosurgery of intracranial tumors. Int J Radiat Oncol Biol Phys 1991; 21: 591–599.

Voges J, Treuer H, Sturm V, et al. Risk analysis of linear accelerator radiosurgery. Int J Radiat Oncol Biol Phys 1996; 36: 1055–1063.

Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000; 47: 291–298.

Vale´ry CA, Cornu P, Noe¨l G, et al. Predictive factors of radiation necrosis after radiosurgery for cerebral metastases. Stereotact Funct Neurosurg 2003; 81: 115–119.

Petrovich Z, Yu C, Giannotta SL, et al. Survival and pattern of failure in brain metastases treated with stereotactic Gamma Knife radiosurgery. J Neurosurg 2002; 97: 499–506.

Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomized trial. Lancet 2004; 363: 1665–1672.

Lutterbach J, Cyron D, Henne K, et al. Radiosurgery followedby planned observation in patients with one to three brain metastases. Neurosurgery 2003; 52: 1066–1074.

Blonigen BJ, Steinmetz RD, Levin L, et al. Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 2010; 77: 996-1001.

Flickinger JC, Lunsford LD, Kondziolka D, et al. Radiosurgery and brain tolerance: An analysis of neurodiagnostic imaging changes following gamma knife radiosurgery for arteriovenous malformations. Int J Radiat Oncol Biol Phys 1992; 23:19–26.

Flickinger JC. An integrated logistic formula for prediction of complications from radiosurgery. Int J Radiat Oncol Biol Phys 1989; 17: 879–885.

Flickinger JC, Kondziolka D, Lunsford LD, et al. Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Arteriovenous Malformation Radiosurgery Study Group. Int J Radiat Oncol Biol Phys 2000; 46: 1143–48.

Cetin IA, Ates R, Dhaens J, et al. Retrospective analysis of linac-based radiosurgery for arteriovenous malformations and testing of the Flickinger formula in predicting radiation injury. Strahlenther Onkol 2012; 188: 1133-8.

Ruben JD, Dally M, Bailey M, et al. Cerebral radiation necrosis: Incidence, outcomes, and risk factors with emphasis on radiation parameters and hemotherapy. Int J Radiat Oncol Biol Phys 2006; 65: 499–508.

Soussain C, Ricard D, Fike JR, et al. CNS complications of radiotherapy and chemotherapy. Lancet 2009; 374: 1639-51.

Kumar AJ, Leeds NE, Fuller GN, et al. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 2000; 217: 377-84.

Shah R, Vattoth S, Jacob R, et al. Radiation necrosis in the brain: Imaging features and differentiation from tumor recurrence. Radiographics 2012; 32: 1343-59.

Patronas NJ, Di Chiro G, Brooks RA, et al. Work in progress: [18F] Fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology 1982; 144: 885-9.

Chao ST, Suh JH, Raja S, et al. The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery. Int J Cancer 2001; 96: 191-7.

Belohlavek O, Simonova G, Kantorova I, et al. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: Can FDG PET help to differentiate radionecrosis from tumour progression? Eur J Nucl Med Mol Imaging 2003; 30: 96-100.

Kosztyla R, Chan EK, Hsu F, et al. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers. Int J Radiat Oncol Biol Phys 2013; 87: 1100-6.

Pirotte B, Goldman S, Massager N, et al. Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas. J Nucl Med. 2004; 45: 1293-8.

Chen W, Silverman DH, Delaloye S, et al. 18F-FDOPA PET imaging of brain tumors: Comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Me 2006; 47: 904-11.

Tsuyuguchi N, Sunada I, Iwai Y, et al. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: Is a differential diagnosis possible? J Neurosurg. 2003; 98(5): 1056-64.

Terakawa Y, Tsuyuguchi N, Iwai Y, et al. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med 2008; 49(5): 694-9.

Galldiks N, Stoffels G, Filss CP, et al. Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis. J Nucl Med 2012; 53(9): 1367-74.

Henze M, Mohammed A, Schlemmer H, et al. Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl- L-tyrosine and 99mTc-MIBI SPET. Eur J Nucl Med Mol Imaging 2002; 29(11): 1455-61.

Demetriades AK, Almeida AC, Bhangoo RS, et al. Applications of positron emission tomography in neuro-oncology: A clinical approach. Surgeon. 2014; 12(3): 148-57.

Chen W. Clinical applications of PET in brain tumors. J Nucl Med 2007; 48(9): 1468-81.

Grosu AL, Astner ST, Riedel E, et al. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases. Int J Radiat Oncol Biol Phys 2011; 81(4): 1049-58.

Lizarraga KJ, Allen-Auerbach M, Czernin J, et al. (18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment. J Nucl Med 2014; 55(1): 30-6.

Schiepers C, Chen W, Cloughesy T, et al. 18F-FDOPA kinetics in brain tumors. J Nucl Med 2007; 48(10): 1651-61.

Roelcke U, Radu EW, Von Ammon K, et al. Alteration of blood-brain barrier in human brain tumors: comparison of [18F]fluorodeoxyglucose, [11C]methionine and rubidium-82 using PET. J Neurol Sci 1995; 132(1): 20-7.

Dequesada IM, Quisling RG, Yachnis A, et al. Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study. Neurosurgery 2008; 63(5): 898-903; discussion 4.

Kerklaan JP, Lycklama a Nijeholt GJ, Wiggenraad RG, et al. SMART syndrome: A late reversible complication after radiation therapy for brain tumours. J Neurol 2011; 258(6): 1098-104.

Barajas RF, Chang JS, Sneed PK, et al. Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 2009; 30(2): 367-72.

Ozsunar Y, Mullins ME, Kwong K, et al. Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging. Acad Radiol 2010; 17(3): 282-90.

Hein PA, Eskey CJ, Dunn JF, et al. Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury. AJNR Am J Neuroradiol 2004; 25(2): 201-9.

Plotkin M, Eisenacher J, Bruhn H, et al. 123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study. J Neurooncol. 2004; 70(1): 49-58.

Sundgren PC. MR spectroscopy in radiation injury. AJNR Am J Neuroradiol 2009; 30(8): 1469-76.

Kimura T, Sako K, Gotoh T, et al. In vivo single-voxel proton MR spectroscopy in brain lesions with ring-like enhancement. NMR Biomed. 2001; 14(6): 339-49.

Posner J. Side eff ects of radiation therapy. In: Posner J, ed.Neurologic complications of cancer. Philadelphia: FA Davis; 1995: 311–37.

Chuba PJ, Aronin P, Bhambhani K, et al. Hyperbaric oxygen therapy for radiation-induced brain injury in children. Cancer 1997; 80: 2005–12.

Feldmeier JJ, Hampson NB. A systematic review of the literatüre reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: An evidence based approach. Undersea Hyperb Med 2002; 29: 4–30.

Chan AS, Cheung M, Law SC, et al. Phase II study of alphatocopherol in improving the cognitive function of patients with temporal lobe radionecrosis. Cancer 2004; 100: 398–404.

Hornsey S, Myers R, Jenkinson T. The reduction of radiation damage to the spinal cord by post-irradiation administration of vasoactive drugs. Int J Radiat Oncol Biol Phys 1990; 18: 1437–42.

Glantz MJ, Burger PC, Friedman AH, et al. Treatment of radiation induced nervous system injury with heparin and warfarin. Neurology 1994; 44: 2020–27.

Torcuator R, Zuniga R, Mohan YS, et al: Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neurooncol 2009; 94: 63–68.

Boothe D, Young R, Yamada Y,et al. Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery. Neuro Oncol 2013; 15(9): 1257-63.

Rahmathulla G1, Recinos PF, Valerio JE,et al. Laser interstitial thermal therapy for focal cerebral radiation necrosis: A case report and literature review. Stereotact Funct Neurosurg 2012; 90: 192–200.




DOI: http://dx.doi.org/10.24294/irr.v0i0.450

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License

This site is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.